This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
This paper presents a retrospective analysis of Ebstein-Barr (EBV) associated complications in renal transplant patients at the Children’s Hospital of Pittsburgh treated with an immunosuppressive regimen consisting of tacrolimus (FK506) and prednisone between 1989–1987. Pre-transplant EBV status was documented for all recipients and for 72% of the donors. By 1995, it was apparent that EBV represented a significant risk for post-transplant complications and so EBV status was prospectively monitored in all patients from then on. The authors divided the patients into 2 groups. Group I consisted of …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.